{"id":174789,"date":"2026-07-28T14:58:15","date_gmt":"2026-07-28T09:28:15","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=174789"},"modified":"2026-07-28T14:58:16","modified_gmt":"2026-07-28T09:28:16","slug":"alembic-pharmaceuticals-share-price-usfda-prucalopride-tablets","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/alembic-pharmaceuticals-share-price-usfda-prucalopride-tablets\/","title":{"rendered":"Alembic Pharmaceuticals Share Price Rises 1.14 Percent After USFDA Final Approval for Prucalopride Tablets"},"content":{"rendered":"<div class=\"meta-block\"><\/div>\n<p style=\"border-left: 4px solid #1F4E79; background: #EBF3FB; padding: 10px 16px; font-style: italic;\"><em>Alembic Pharmaceuticals share price Rs 823.70, up Rs 9.25 or 1.14 percent. Day high Rs 826.85, day low Rs 812.90. Volume 4,466 shares versus 5-day average 3,504 shares.<\/em><\/p>\n<p>Alembic Pharmaceuticals share price moved higher on 28 July 2026 after the company secured a fresh regulatory approval in the United States. The stock was quoting at Rs 823.70, up Rs 9.25 or 1.14 percent, as investors responded positively to the company&#8217;s expanding portfolio of approved generic products.<\/p>\n<p>Alembic Pharmaceuticals has received final approval from the US Food and Drug Administration for its Abbreviated New Drug Application Prucalopride Tablets, 1 mg and 2 mg. The approved ANDA is therapeutically equivalent to the reference listed drug product, Motegrity Tablets, 1 mg and 2 mg, of Takeda Pharmaceuticals USA Inc. Prucalopride tablets are a serotonin-4 receptor agonist indicated for the treatment of chronic idiopathic constipation in adults.<\/p>\n<p style=\"margin-top: 24px;\"><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&amp;utm_medium=alembic-pharmaceuticals-share-price-usfda-nod\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/alembic-pharmaceuticals-share-price-usfda-prucalopride-tablets\/#Alembic_Pharmaceuticals_Share_Price_Today_Key_Trading_Levels\" title=\"Alembic Pharmaceuticals Share Price Today: Key Trading Levels\">Alembic Pharmaceuticals Share Price Today: Key Trading Levels<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/alembic-pharmaceuticals-share-price-usfda-prucalopride-tablets\/#What_the_Prucalopride_Tablets_Approval_Means\" title=\"What the Prucalopride Tablets Approval Means\">What the Prucalopride Tablets Approval Means<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/alembic-pharmaceuticals-share-price-usfda-prucalopride-tablets\/#Alembic_Pharmaceuticals_US_Generics_Pipeline\" title=\"Alembic Pharmaceuticals&#8217; US Generics Pipeline\">Alembic Pharmaceuticals&#8217; US Generics Pipeline<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/alembic-pharmaceuticals-share-price-usfda-prucalopride-tablets\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/alembic-pharmaceuticals-share-price-usfda-prucalopride-tablets\/#FAQs\" title=\"FAQs\">FAQs<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/alembic-pharmaceuticals-share-price-usfda-prucalopride-tablets\/#Why_did_Alembic_Pharmaceuticals_share_price_rise_on_28_July_2026\" title=\"Why did Alembic Pharmaceuticals share price rise on 28 July 2026?\">Why did Alembic Pharmaceuticals share price rise on 28 July 2026?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/alembic-pharmaceuticals-share-price-usfda-prucalopride-tablets\/#What_is_Prucalopride_used_to_treat\" title=\"What is Prucalopride used to treat?\">What is Prucalopride used to treat?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/alembic-pharmaceuticals-share-price-usfda-prucalopride-tablets\/#What_is_the_reference_drug_for_Alembic_Pharmaceuticals_approved_Prucalopride_ANDA\" title=\"What is the reference drug for Alembic Pharmaceuticals&#8217; approved Prucalopride ANDA?\">What is the reference drug for Alembic Pharmaceuticals&#8217; approved Prucalopride ANDA?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/alembic-pharmaceuticals-share-price-usfda-prucalopride-tablets\/#What_was_the_intraday_range_for_Alembic_Pharmaceuticals_share_price_today\" title=\"What was the intraday range for Alembic Pharmaceuticals share price today?\">What was the intraday range for Alembic Pharmaceuticals share price today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/alembic-pharmaceuticals-share-price-usfda-prucalopride-tablets\/#What_was_the_trading_volume_for_Alembic_Pharmaceuticals_share_price_today\" title=\"What was the trading volume for Alembic Pharmaceuticals share price today?\">What was the trading volume for Alembic Pharmaceuticals share price today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/alembic-pharmaceuticals-share-price-usfda-prucalopride-tablets\/#Is_Alembic_Pharmaceuticals_share_price_a_good_buy_after_the_USFDA_approval\" title=\"Is Alembic Pharmaceuticals share price a good buy after the USFDA approval?\">Is Alembic Pharmaceuticals share price a good buy after the USFDA approval?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/alembic-pharmaceuticals-share-price-usfda-prucalopride-tablets\/#What_regulatory_body_approved_Alembic_Pharmaceuticals_Prucalopride_Tablets\" title=\"What regulatory body approved Alembic Pharmaceuticals&#8217; Prucalopride Tablets?\">What regulatory body approved Alembic Pharmaceuticals&#8217; Prucalopride Tablets?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Alembic_Pharmaceuticals_Share_Price_Today_Key_Trading_Levels\"><\/span><strong>Alembic Pharmaceuticals Share Price Today: Key Trading Levels<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Alembic Pharmaceuticals share price touched an intraday high of Rs 826.85 and an intraday low of Rs 812.90 during Tuesday&#8217;s session. The stock was trading with volumes of 4,466 shares, compared to its five day average of 3,504 shares, an increase of 27.46 percent, indicating higher than usual participation around the approval news.<\/p>\n<table style=\"width: 100%; border-collapse: collapse;\" border=\"1\">\n<thead>\n<tr style=\"background: #000000; color: #ffffff;\">\n<th>Metric<\/th>\n<th>Value<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Company<\/td>\n<td><a href=\"https:\/\/univest.in\/stocks\/aplltd\/alembic-pharmaceuticals-ltd-share-price-today\">Alembic Pharmaceuticals<\/a><\/td>\n<\/tr>\n<tr>\n<td>CMP<\/td>\n<td>Rs 823.70<\/td>\n<\/tr>\n<tr>\n<td>Change<\/td>\n<td>Rs +9.25 (+1.14 percent)<\/td>\n<\/tr>\n<tr>\n<td>Intraday High<\/td>\n<td>Rs 826.85<\/td>\n<\/tr>\n<tr>\n<td>Intraday Low<\/td>\n<td>Rs 812.90<\/td>\n<\/tr>\n<tr>\n<td>Volume<\/td>\n<td>4,466 shares<\/td>\n<\/tr>\n<tr>\n<td>5 Day Average Volume<\/td>\n<td>3,504 shares<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p style=\"margin-top: 24px;\"><a href=\"https:\/\/univest.in\/screeners\"><strong>Check Live Stock Screener for More Pharma Sector Picks<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"What_the_Prucalopride_Tablets_Approval_Means\"><\/span><strong>What the Prucalopride Tablets Approval Means<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Prucalopride tablets work as a serotonin-4 receptor agonist and are used to treat chronic idiopathic constipation in adults, a condition affecting a meaningful patient population in the United States. The reference product, Motegrity Tablets from Takeda Pharmaceuticals USA, gives Alembic Pharmaceuticals a clear branded benchmark to compete against as it rolls out its generic version in the American market, one of the largest and most closely watched pharmaceutical markets in the world.<\/p>\n<p>Alembic Pharmaceuticals share price reaction reflects the market&#8217;s generally favourable view of USFDA approvals, since final approval clears the last major regulatory hurdle before a company can begin commercial shipments of the approved generic product in the United States, one of the largest and most closely watched pharmaceutical markets globally. Such approvals also add to a company&#8217;s long-term revenue visibility once commercial launch begins.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Alembic_Pharmaceuticals_US_Generics_Pipeline\"><\/span><strong>Alembic Pharmaceuticals&#8217; US Generics Pipeline<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Alembic Pharmaceuticals has built a sizeable portfolio of ANDA approvals over the years across therapeutic areas including gastroenterology, cardiovascular, and anti-infective segments, with the US generics business remaining a key growth driver for the company alongside its domestic formulations and active pharmaceutical ingredients operations. The company has consistently added to its filed and approved ANDA count over recent years as part of a broader strategy to diversify its product mix in the regulated US market and reduce dependence on any single therapeutic category.<\/p>\n<p style=\"margin-top: 24px;\"><em>Download the <a href=\"https:\/\/apps.apple.com\/in\/app\/univest\/id1553969316\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"https:\/\/play.google.com\/store\/apps\/details?id=com.univest.app\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track Alembic Pharmaceuticals share price movements live and get USFDA approval alerts.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Alembic Pharmaceuticals share price rose 1.14 percent to Rs 823.70 on 28 July 2026 after the company received final USFDA approval for its Prucalopride Tablets ANDA, therapeutically equivalent to Takeda&#8217;s Motegrity Tablets. The approval adds one more product to Alembic Pharmaceuticals&#8217; growing list of US generic approvals across multiple therapeutic categories. Investors tracking Alembic Pharmaceuticals share price should watch for the product&#8217;s commercial launch timeline and consult a SEBI-registered investment advisor before making any investment decision.<\/p>\n<div style=\"background: #CC0000; border-radius: 8px; padding: 16px 20px; margin: 24px 0;\">\n<p style=\"color: #ffffff; font-size: 13px; line-height: 1.7; margin: 0;\"><strong style=\"color: #ffffff;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"FAQs\"><\/span><strong>FAQs<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Why_did_Alembic_Pharmaceuticals_share_price_rise_on_28_July_2026\"><\/span><strong>Why did Alembic Pharmaceuticals share price rise on 28 July 2026?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Alembic Pharmaceuticals share price rose 1.14 percent to Rs 823.70 after the company received final USFDA approval for its Prucalopride Tablets ANDA in 1 mg and 2 mg strengths.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Prucalopride_used_to_treat\"><\/span><strong>What is Prucalopride used to treat?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Prucalopride tablets are a serotonin-4 receptor agonist indicated for the treatment of chronic idiopathic constipation in adults.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_reference_drug_for_Alembic_Pharmaceuticals_approved_Prucalopride_ANDA\"><\/span><strong>What is the reference drug for Alembic Pharmaceuticals&#8217; approved Prucalopride ANDA?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The approved ANDA is therapeutically equivalent to the reference listed drug product, Motegrity Tablets, 1 mg and 2 mg, of Takeda Pharmaceuticals USA Inc.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_was_the_intraday_range_for_Alembic_Pharmaceuticals_share_price_today\"><\/span><strong>What was the intraday range for Alembic Pharmaceuticals share price today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Alembic Pharmaceuticals share price touched an intraday high of Rs 826.85 and an intraday low of Rs 812.90 during the session on 28 July 2026.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_was_the_trading_volume_for_Alembic_Pharmaceuticals_share_price_today\"><\/span><strong>What was the trading volume for Alembic Pharmaceuticals share price today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Alembic Pharmaceuticals share price traded with volumes of 4,466 shares, compared to its five day average of 3,504 shares, an increase of 27.46 percent.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Alembic_Pharmaceuticals_share_price_a_good_buy_after_the_USFDA_approval\"><\/span><strong>Is Alembic Pharmaceuticals share price a good buy after the USFDA approval?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Investors should evaluate Alembic Pharmaceuticals share price alongside the company&#8217;s broader US generics pipeline, valuation, and sector trends, and consult a SEBI-registered investment advisor before making any buy, hold, or sell decisions.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_regulatory_body_approved_Alembic_Pharmaceuticals_Prucalopride_Tablets\"><\/span><strong>What regulatory body approved Alembic Pharmaceuticals&#8217; Prucalopride Tablets?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The US Food and Drug Administration granted final approval for Alembic Pharmaceuticals&#8217; Abbreviated New Drug Application for Prucalopride Tablets, 1 mg and 2 mg.<\/p>\n<div class=\"faq-schema\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Alembic Pharmaceuticals share price rose 1.14 percent to Rs 823.70 after the company received final USFDA approval for its Prucalopride Tablets ANDA in 1 mg and 2 mg strengths.<\/p>\n","protected":false},"author":35,"featured_media":174777,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[3802],"class_list":["post-174789","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["174777"],"_edit_lock":["1785230900:29"],"_last_editor_used_jetpack":["block-editor"],"rank_math_primary_category":["842"],"rank_math_seo_score":["73"],"rank_math_title":["Alembic Pharmaceuticals Share Price Gains on USFDA Nod"],"rank_math_description":["Alembic Pharmaceuticals share price rose 1.14 percent to Rs 823.70 after the company received final USFDA approval for its Prucalopride Tablets ANDA in 1 mg and 2 mg strengths."],"rank_math_focus_keyword":["Alembic Pharmaceuticals share price"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"],"_edit_last":["29"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["31727"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/07\/alembic-pharmaceuticals-share-price-usfda-prucalopride-tablets.png","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/174789","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/35"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=174789"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/174789\/revisions"}],"predecessor-version":[{"id":174819,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/174789\/revisions\/174819"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/174777"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=174789"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=174789"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=174789"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}